Emcure Pharma Anil Kothiyal to resign as President - India Sales & Marketing
Pune: Emcure Pharmaceuticals Limited has announced the resignation of Anil Kothiyal, President - India Sales & Marketing and Senior Management Personnel of the Company effective from close of business hours on June 06, 2025, due to personal reasons.
Anil Kothiyal has an impressive 3 decades career in the pharmaceutical industry. Anil’s career has seen him in key roles at renowned companies like Glenmark Pharmaceuticals, Abbott Healthcare, Nicholas Piramal Limited, and Alembic Limited. His strategic foresight and operational acumen have consistently fuelled business growth and success, setting him apart as a visionary leader.
Read also: Emcure Pharma launches new dermatology-focused arm Emcutix Biopharma
Anil holds a PGDBM in Marketing from IMT, Ghaziabad, a PGDCA from Bombay Institute of Technology, Bombay, and a Bachelor of Science from DAV College, Dehradun. Anil’s three-decade journey is a testament to his effective leadership, innovative thinking, and a proven track record of success in the ever-changing pharmaceutical industry.
Emcure Pharmaceuticals Ltd., established in 1981, is an Indian pharma company headquartered in Pune, India. It is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure is an R&D driven company that develops and manufactures a wide range of differentiated pharmaceutical products. Emcure is present in 70+ countries globally including Europe and Canada.
